Evidence map›Paper›PMID 29888318›Full record

ReviewEJNMMI radiopharmacy and chemistry2018

A random walk approach to estimate the confinement of α-particle emitters in nanoparticles for targeted radionuclide therapy.

Uwe Holzwarth, Isaac Ojea Jimenez, Luigi Calzolai

Open access · goldAbstract readReview
In one paragraph

Review in EJNMMI radiopharmacy and chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Study ofMaterials (Basel, Switzerland) · 2022
    Article
  6. Review
  7. Review
  8. Design and Evaluation ofInternational journal of molecular sciences · 2021
    Article
  9. A review of advances in the last decade on targeted cancer therapy usingAmerican journal of nuclear medicine and molecular imaging · 2021
    Review
  10. Article
  11. Article
  12. Design and Evaluation ofMaterials (Basel, Switzerland) · 2020
    Article
  13. Nanoparticles in Targeted Alpha Therapy.Nanomaterials (Basel, Switzerland) · 2020
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Uwe HolzwarthEuropean Commission, Joint Research Centre, Via Enrico Fermi 2749, 21027 Ispra, VA Italy.ORCID 0000-0002-7382-6837
Isaac Ojea JimenezEuropean Commission, Joint Research Centre, Via Enrico Fermi 2749, 21027 Ispra, VA Italy.
Luigi CalzolaiEuropean Commission, Joint Research Centre, Via Enrico Fermi 2749, 21027 Ispra, VA Italy.
European Commission · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTargeted radionuclide therapy is a highly efficient but still underused treatment modality for various types of cancers that uses so far mainly readily available β-emitting radionuclides. By using α-particle emitters several shortcomings due to hypoxia, cell proliferation and in the selected treatment of small volumes such as micrometastasis could be overcome. To enable efficient targeting longer-lived α-particle emitters are required. These are the starting point of decay chains emitting several α-particles delivering extremely high radiation doses into small treatment volumes. However, as a consequence of the α-decay the daughter nuclides receive high recoil energies that cannot be managed by chemical radiolabelling techniques. By safe encapsulation of all α-emitters in the decay chain in properly sized nanocarriers their release may be avoided.

resultsThe encapsulation of small core nanoparticles loaded with the radionuclide in a shell structure that safely confines the recoiling daughter nuclides promises good tumour targeting, penetration and uptake, provided these nanostructures can be kept small enough. A model for spherical nanoparticles is proposed that allows an estimate of the fraction of recoiling α-particle emitters that may escape from the nanoparticles as a function of their size. The model treats the recoil ranges of the daughter nuclides as approximately equidistant steps with arbitrary orientation in a three-dimensional random walk model.

conclusionsThe presented model allows an estimate of the fraction of α-particles that are emitted from outside the nanoparticle when its size is reduced below the radius that guarantees complete confinement of all radioactive daughter nuclides. Smaller nanoparticle size with reduced retention of daughter radionuclides might be tolerated when the effects can be compensated by fast internalisation of the nanoparticles by the target cells.

Indexed as

223Ra224Ra225AcConfinement of daughter radionuclides in nanoparticlesNanocarriersNanomedicineRecoil energyTargeted radionuclide therapyα-particle emitters

Identifiers

PMID29888318
PMCPMC5976682
OpenAlexW2805094557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.